Phase I study of combination therapy with intravenous cidofovir and oral ganciclovir for cytomegalovirus retinitis in patients with AIDS

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 528-533

  Jacobson, Mark A ^a,b,c   Wilson, Scarlette ^a,b   Stanley, Hopkins ^a,b   Holtzer, Christopher ^a,b   Cherrington, Julie ^a,b   Safrin, Sharon ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b GILEAD SCIENCES   (United States)

^c Ward 84 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; IRIDOCYCLITIS; MALE; MUSCLE HYPOTONIA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RETINITIS; VIRUS INHIBITION;

EID: 0033020330     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515167     Document Type: Article

References (26)

1. 1. Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis 1992;14:608-15.
2. 2. Hoover DR, Saah AJ, Bacellar H, et al. Clinical manifestations of AIDS in the era of pneumocystis prophylaxis. N Engl J Med 1993;329: 1922-6.
3. 3. Palestine AG, Polis MA, De Smet MD, et al. A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS. Ann Intern Med 1991;115:665-73.
4. 4. Spector SA, Weingeist T, Pollard RB, et al. A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. J Infect Dis 1993;168:557-63.
5. 5. Musch DC, Martin DF, Gordon JF, et al. Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. N Engl J Med 1997;337:83-90.
6. 6. Martin DF, Kupperman B, Wolitz R, et al. Combined oral ganciclovir and intravitreal ganciclovir implant for treatment of patients with cytomegalovirus retinitis: a randomized, controlled study [abstract no LB-9]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
7. 7. The Oral Ganciclovir European and Australian Cooperative Study Group. Intravenous versus oral ganciclovir: European/Australian comparative study of efficacy and safety in the prevention of cytomegalovirus retinitis recurrence in patients with AIDS. AIDS 1995;9:471-7.
8. 8. Drew WL, Ives D, Lalezari J, et al. Oral ganciclovir as maintenance treatment for cytomegalovirus retinitis in patients with AIDS. N Engl J Med 1995;333:615-20.
9. 9. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. Ann Intern Med 1997;126:264-74.
10. 10. Lalezari JP, Stagg RJ, Kuppermann BD, et al. Intravenous cidofovir for peripheral CMV retinitis in patients with AIDS. Ann Intern Med 1997; 126:257-63.
11. 11. Snoeck R, Andrei G, Schols D, et al. Activity of different antiviral drug combinations against human cytomegalovirus replication in vitro. Eur J Clin Microbiol 1992;11:1144-55.
12. 12. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41(RR-17):1-19.
13. 13. Chernoff D, Miner R, Hoo C, et al. Quantification of cytomegalovirus DNA in peripheral blood leukocytes by a branched-DNA signal amplification assay. J Clin Microbiol 1997;135:2740-4.
14. 14. Palau LA, Tufty GT, Pankey GA. Recurrent iritis after intravenous administration of cidofovir. Clin Infect Dis 1997;25:337-8.
15. 15. Davis JL, Taskintuna I, Freeman WR, et al. Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol 1997;115:733-7.
16. 16. Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, de Clerq E, Freeman WR. Intravitreal cidofovir treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology 1995;102:533-43.
17. 17. Lalezari JP, Drew WL, Glutzer E, et al. (S)-1-[3-Hydroxy-2-(phosphonylmethoxy)propyl]cytosine (cidofovir): results of a phase 1/2 study of a novel antiviral nucleotide analogue. J Infect Dis 1995;171:788-96.
18. 18. Polis MA, Spooner KM, Baird BF, et al. Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria. Antimicrob Agents Chemother 1995;39:882-6.
19. 19. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Foscarnet-ganciclovir cytomegalovirus retinitis trial, 4: visual outcomes. Ophthalmology 1994;101:1250-61.
20. 20. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Combination foscarnet and ganciclovir therapy vs. monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. Arch Ophthalmol 1996;114:23-33.
21. 21. Manischewitz JF, Quinnan GV, Lane HC, Wittek AE. Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro. Antimicrob Agents Chemother 1990;34:373-5.
22. 22. Freitas VR, Fraser-Smith EB, Matthews TR. Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo. Antiviral Res 1989;12:205-12.
23. 23. Torriani FJ, MacDonald JC, Karavellas M, Freeman WR. Lack of progression after discontinuation of maintenance therapy for cytomegalovirus retinitis in AIDS patients responding to highly active antiretroviral therapy [abstract no I-33]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
24. 24. Tural C, Sirera G, Andreu D, et al. Long lasting remission of cytomegalovirus retinitis without maintenance therapy in HIV+ patients [abstract no I-36]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
25. 25. Whitcup SM, Fortin E, Nussenblatt RB, et al. Therapeutic effect of combination antiretroviral therapy on cytomegalovirus retinitis. JAMA 1997; 277:1519-20.
26. 26. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Cytomegalovirus (CMV) culture results, drug resistance, and clinical outcomes in patients with AIDS and CMV retinitis treated with either foscarnet or ganciclovir. J Infect Dis 1997;176:50-8.